Pharmacy News

Early tecovirimat treatment for mpox disease may benefit people with HIV

Early intervention with tecovirimat may stop an mpox infection from advancing to the stages of severe disease in people living with HIV (PWH), new research suggests.

Research looks at Paxlovid for long COVID risk

Paxlovid did not reduce the risk of developing long COVID in vaccinated, nonhospitalized adults, according to new data published in the Journal of Medical Virology.

Labeling will change for two cholesterol-lowering medications

Effective immediately, FDA has changed the labels on two medications used to bring down LDL cholesterol levels: bempedoic acid (Nexletol) and bempedoic acid/ezetimibe (Nexlizet).

FDA finalizes guidance over benzene carcinogen in drugs

In final guidance that takes effect immediately, FDA restricted manufacturers from using benzene in new and existing prescription drugs as well as nonprescription interventions.

FDA approves safety labeling changes for opioids

FDA gave final approval to required safety labeling updates for opioids. The updates, first included in an April 2023 drug safety communication, include the addition of language stating the risk of overdose increases with higher doses for all opioid analgesics and that immediate-release opioids should not be used for an extended period of time unless a patient’s pain is so severe that it cannot be controlled otherwise.